Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Claudin 5 (CLDN5) (C-Term) Peptide

CLDN5 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN975043

Quick Overview for Claudin 5 (CLDN5) (C-Term) Peptide (ABIN975043)

Target

Claudin 5 (CLDN5)

Origin

Human

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-CLDN5 antibody (Catalog #: ARP33627_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Claudin 5 (CLDN5)

    Background

    CLDN5 is a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets. Mutations in this gene have been found in patients with velocardiofacial syndrome.This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets. Mutations in this gene have been found in patients with velocardiofacial syndrome. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: AWAL, BEC1, CPETRL1, TMVCF

    Protein Interaction Partner: CLDN3,CLDN5,MPDZ,TJP1,CLDN1,CLDN3,TJP1

    Protein Size: 218

    Molecular Weight

    23 kDa

    Gene ID

    7122

    NCBI Accession

    NM_003277, NP_003268

    UniProt

    O00501
You are here:
Chat with us!